The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Natera, Inc. (NASDAQ:NTRA) stands against other ...

Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Ardelyx, Inc. (NASDAQ:ARDX) stands against the other best ...

Investing in biotech stocks isn't for everyone. An unsuccessful clinical trial can cause a huge decline. The competition is usually fierce. Volatility is almost always present. However, some biotech ...

Over the past five years, Celgene (NASDAQ: CELG) stock has soared 280%. That's better than any other biotech with a market cap of $50 billion or more. Celgene's past success stemmed primarily from ...

We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. The tenth stock on our list is Legend Biotech ...

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector. Can battered biotech stocks rebound in 2025?

Biotech firms like Axsome and BioNTech develop innovative treatments, offering growth potential for investors. Strong financial positions reduce risk in biotech investing, prioritizing firms with both ...

Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.